ABCL635

Phase 2

00%

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

12mo

ABCLPhase 2$671M

ABCL635 Phase 2 Results Expected

ABCL635• Vasomotor Symptoms Associated With Menopause136

Feb 15Estimated

00%

Competitive Landscape

0 competitors in Vasomotor Symptoms Associated With Menopause

Drug Information

Target Indication

Vasomotor Symptoms Associated With Menopause

Clinical Trial

Last updated: 1/10/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ABCL

AbCellera Biologics Inc.